SYBX
SYNLOGIC, INC.Company Information
- Company Name
- SYNLOGIC, INC.
- CIK
- CIK0001527599
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SYBX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SYBX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-10-29
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 2,487
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 23,763
- Shares outstanding
- 12,418,592
- Ownership
- 0.19%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -0.85%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 13 | 14 | 15 | 16 | 17 | 17 | 19 | 19 | 20 | 25 | 24 | 25 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | 0 | 0 | 0 | 7 | 24 | 9 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Assets Current | 13 | 15 | 15 | 17 | 17 | 18 | 20 | 21 | 22 | 35 | 50 | 38 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Assets | 13 | 15 | 15 | 17 | 17 | 18 | 20 | 21 | 22 | 36 | 76 | 66 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 6 | 6 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 12 | 13 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 1 | 2 | 4 | 6 | 5 | 5 | 7 | 8 | 6 | 11 | 30 | 9 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 457 | 457 | 457 | 457 | 457 | 457 | 457 | 457 | 462 | 462 | 454 | 446 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | 3 | 5 | 4 | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -443 | -442 | -443 | -444 | -442 | -441 | -442 | -441 | -444 | -446 | -418 | -400 | ||||||
| Treasury Stock Value | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | ||||||
| Stockholders Equity | 12 | 13 | 12 | 10 | 13 | 13 | 13 | 13 | 13 | 9 | 33 | 43 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 12 | 12 | 14 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities And Stockholders Equity | 13 | 15 | 15 | 17 | 17 | 18 | 20 | 21 | 22 | 36 | 76 | 66 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 12 | 12 | 14 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 5 | ||||||
| Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSYNLOGIC, INC. (SYBX) — SEC Financial Statements & Analysis
SYNLOGIC, INC. (SYBX) is a pharmaceutical preparations company, incorporated in DE. SYNLOGIC, INC. trades on OTC as: SYBX. SYNLOGIC, INC. (SYBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, SYNLOGIC, INC. carries a market cap of $8.71M, a P/E ratio of -13.29x, a P/B ratio of 0.72x, a P/S ratio of 2134.34x, an enterprise value of $-4.48M, and an EV/EBITDA multiple of 0.96x. On profitability, it posts an operating margin of -511875.00%, a net margin of -291987.50%, a Return on Equity (ROE) of -5.32%, a Return on Assets (ROA) of -4.25%, and a Return on Invested Capital (ROIC) of -145.76%. Per share, it reports EPS of $-0.05, diluted EPS of $-0.05, free cash flow per share of $-0.31, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -37.20% year-over-year, and EPS growth of -37.70% year-over-year. On the balance sheet, it maintains a current ratio of 9.19x, a quick ratio of 9.02x, working capital of $11.97M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.11, an interest coverage ratio of -49815.00x, free cash flow of $-3.84M (TTM), and net debt of $-13.18M. Figures sourced from SEC EDGAR.
- Market Cap
- $8.71M
- P/E TTM
- -13.29x
- EPS TTM
- $-0.05
- P/B TTM
- 0.72x
- ROE TTM
- -5.32%
- ROA TTM
- -4.25%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $-3.84M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SYNLOGIC, INC. in?
SYNLOGIC, INC. (SYBX) operates in the Pharmaceutical Preparations industry.
What exchange does SYBX trade on?
SYNLOGIC, INC. (SYBX) trades on the OTC.
Where is SYNLOGIC, INC. incorporated?
SYNLOGIC, INC. is incorporated in DE.
When was SYNLOGIC, INC. (SYBX)'s most recent SEC filing?
SYNLOGIC, INC. (SYBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is SYBX's market cap?
SYNLOGIC, INC. (SYBX) has a market capitalization of $8.71M as of 2026-06-30.
What is SYBX's EPS (earnings per share)?
SYNLOGIC, INC. (SYBX)'s trailing twelve month EPS is $-0.05 as of 2026-06-30.
What is SYBX's ROE (return on equity)?
SYNLOGIC, INC. (SYBX)'s trailing twelve month Return on Equity (ROE) is -5.32% as of 2026-06-30.
What is SYBX's ROA (return on assets)?
SYNLOGIC, INC. (SYBX)'s trailing twelve month Return on Assets (ROA) is -4.25% as of 2026-06-30.
What is SYBX's ROIC (return on invested capital)?
SYNLOGIC, INC. (SYBX)'s trailing twelve month Return on Invested Capital (ROIC) is -145.76% as of 2023-12-31.
What is SYBX's EV/EBITDA?
SYNLOGIC, INC. (SYBX)'s trailing twelve month EV/EBITDA is 0.96x as of 2026-06-30.